Evidence map›Paper›PMID 26452503›Full record

ArticleJournal of physiology and biochemistry2015

Gene expression of different adipose tissues of severely obese women with or without a dysmetabolic profile.

P Mauriège, D R Joanisse, S CasparBauguil, A Cartier, I Lemieux, J Bergeron, S Biron, P Marceau, D Richard

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

P MauriègeDepartment of Kinesiology, Faculty of Medicine, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, PEPS, Room 0290C, Québec, G1V 0A6, QC, Canada. pascale.mauriege@kin.ulaval.ca.
D R JoanisseDepartment of Kinesiology, Faculty of Medicine, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, PEPS, Room 0290C, Québec, G1V 0A6, QC, Canada.
S CasparBauguilService de Biochimie, CHU de Toulouse; Laboratoire de recherche sur les Obésités, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), UMR 1048 Inserm, CHU de Toulouse, France.
A CartierCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Québec, Canada.
I LemieuxCentre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Laval University, Québec, Canada.
J BergeronAxe Endocrinologie et Néphrologie, Centre de Recherche du Centre Hospitalier Universitaire de Québec, Québec, Canada.
S BironDepartment of Surgery, Faculty of Medicine; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
P MarceauDepartment of Surgery, Faculty of Medicine; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
D RichardDepartment of Physiology, Faculty of Medicine, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
Institut Universitaire de Cardiologie et de Pneumologie de Québec · CAUniversité Laval · CACentre hospitalier universitaire de Québec · CAInstitut des Maladies Métaboliques et Cardiovasculaires · FR

Funding

Canadian Institutes of Health Research OHP 67388
6 · The paper itself

Abstract

Despite well-established variations in the health risks posed by visceral vs. subcutaneous abdominal (SCABD) fat depots, surprisingly little is known on the differences within a given adipose tissue (AT) among severely obese patients displaying varying metabolic dysfunction. We thus compared, by quantitative PCR, the expression profile of a number of genes in the SCABD, omental (OME), and mesenteric (MES) depots of severely obese women with (DYS; n = 25) or without (NDYS; n = 23) a dysmetabolic profile. Fasting insulinemia and HOmeostasis Model Assessment-insulin resistance (HOMA-IR) were higher and plasma adiponectin level lower in DYS women (p < 0.05). Among enzymes involved in fatty acid metabolism and local cortisol production, phosphodiesterase-3B expression was lower in SCABD and MES fat, while 11β-hydroxysteroid dehydrogenase type 1 mRNA levels were higher in visceral depots of DYS women (p < 0.05). Regarding vascular homeostasis and inflammation, plasminogen activator inhibitor-1 and interleukin-6 mRNA levels were higher in OME fat, while adiponectin expression was lower in SCABD and OME ATs of DYS women (p < 0.05). Finally, HOMA-IR was positively associated with SCABD AT IL6 mRNA, only in DYS women (r = 0.47; p < 0.05). In conclusion, although metabolic and secretory characteristics of all depots vary with subjects' metabolic profile, we find little evidence for a protective role of SCABD AT and no evidence for a further deleterious role of MES fat in DYS vs. NDYS severely obese women. Regional variation in the overall gene expression revealed that OME and MES fat were more closely related to each other in DYS women, while SCABD and MES depots showed greater resemblance in NDYS women.

Indexed as

TranscriptomeAdipokinesAdipose Tissue, WhiteAdultBiomarkersFemaleHumansHydrocortisoneInsulin ResistanceMetabolic DiseasesMetabolic Networks and PathwaysMiddle AgedObesity, MorbidOrgan SpecificityRNA, MessengerAdipokinesBiomarkersHydrocortisoneRNA, MessengerAdipogenesisAdipokinesAdipose tissueFatty acid metabolismInflammationInsulin resistance

Identifiers

PMID26452503
OpenAlexW1847944524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.